Title : High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.

Pub. Date : 2021 Jun

PMID : 33850004






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study demonstrates that idasanutlin can overcome resistance to the BCL-2 inhibitor venetoclax in preclinical neuroblastoma model systems, which supports clinical development of a treatment strategy combining the two therapies. RG7388 BCL2 apoptosis regulator Homo sapiens